Sébastien Poulin
YOU?
Author Swipe
View article: La prise en charge de l'hépatite B chronique: mise à jour 2025 des lignes directrices de l'Association canadienne pour l'étude du foie et de l'Association pour la microbiologie médicale et l'infectiologie Canada
La prise en charge de l'hépatite B chronique: mise à jour 2025 des lignes directrices de l'Association canadienne pour l'étude du foie et de l'Association pour la microbiologie médicale et l'infectiologie Canada Open
L'infection chronique par le virus de l'hépatite B (VHB) pose d'importants problèmes de santé publique au Canada, en particulier chez les nouveaux arrivants provenant de régions à forte prévalence du VHB. Conformément à l'objectif de l'Org…
View article: The management of chronic hepatitis B: 2025 Guidelines update from the Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada
The management of chronic hepatitis B: 2025 Guidelines update from the Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada Open
Chronic hepatitis B virus (HBV) infection poses significant public health challenges in Canada, particularly among newcomers from regions with high HBV prevalence. In alignment with the World Health Organization’s goal of HBV elimination b…
View article: Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry Open
In Canada, IV dalbavancin is used as both directed and empiric therapy to treat ABSSSI as well as off-label (bone/joint, bacteremia/vascular, endocarditis, device-related) infections. It is used in both outpatient and inpatient settings du…
View article: Seroprevalence and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Among Incarcerated Adult Men in Quebec, Canada, 2021
Seroprevalence and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Among Incarcerated Adult Men in Quebec, Canada, 2021 Open
Background People in prison are at increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We examined the seroprevalence of SARS-CoV-2 and associated carceral risk factors among incarcerated adult men in …
View article: Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial Open
View article: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial Open
View article: Seroprevalence and Risk Factors for SARS-CoV-2 Among Incarcerated Adult Men in Quebec, Canada (2021): A Cross-Sectional Study
Seroprevalence and Risk Factors for SARS-CoV-2 Among Incarcerated Adult Men in Quebec, Canada (2021): A Cross-Sectional Study Open
View article: Pneumocystis jirovecii Pneumonia Outbreaks in Renal Transplant Populations in Quebec, Canada: Clinical and Molecular Epidemiology
Pneumocystis jirovecii Pneumonia Outbreaks in Renal Transplant Populations in Quebec, Canada: Clinical and Molecular Epidemiology Open